Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Deferred Versus Immediate Stent Implantation for Preventing Microvascular Dysfunction and Improving Clinical Outcomes in Patients With ST-Segment Elevation Myocardial Infarction (SALVAGE)

NCT03581513 is registered in ClinicalTrials.gov with Harbin Medical University as lead sponsor.

NCT NCT03581513
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03581513 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Deferred Versus Immediate Stent Implantation for Preventing Microvascular Dysfunction and Improving Clinical Outcomes in Patients With ST-Segment Elevation Myocardial Infarction (SALVAGE)
Lead sponsor
Harbin Medical University
Phase
Not applicable
Overall status
Terminated
Start date
December 20, 2017
Completion date
August 31, 2021
Enrollment
629 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

microcirculatory perfusion, st elevation myocardial infarction